Patent Assignment
Reel/Frame 042418/0481
Change of Name
Recorded: 2017-05-05
Pages: 4
Assignor
TIGERCAT PHARMA, INC.
Executed: 2016-05-27
Assignee
MENLO THERAPEUTICS INC.
4085 CAMPBELL AVENUE, SUITE 200, MENLO PARK, CALIFORNIA, 94025
Covered Properties
(2)
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Use of Nk-1 Receptor Antagonists in Pruritus
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 5, 2017
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 042258/0517 →
Assignment of Assignor's Interest
May 5, 2017
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 042259/0057 →
Patent Security Agreement
Mar 9, 2020
From: MENLO THERAPEUTICS INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 052130/0980 →
Change of Name
Dec 1, 2020
From: MENLO THERAPEUTICS INC.
To: VYNE THERAPEUTICS INC.
Reel/Frame 054558/0437 →
Release of Security Interest
Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE THERAPEUTICS INC. (F/K/A MENLO THERAPEUTICS INC. AND SUCCESSOR-IN-INTEREST TO VYNE PHARMACEUTICALS LTD., F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057531/0986 →